Hong Kong biotech start-up is set to list on the Nasdaq in a SPAC merger

Hong Kong biotech company Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, according to a source close to the deal. The SPAC is already traded on the Nasdaq under the ticker ARTU.

Read more: https://cnb.cx/3kuWZZn

Comments are closed.

Proudly powered by WordPress | Theme: Baskerville 2 by Anders Noren.

Up ↑